Eosinophils derived from acute promyelocytic leukemia cells after arsenic trioxide treatment.
Yamamoto
Kazuhito
K
Emi
Nobuhiko
N
Kajiguchi
Tomohiro
T
Yamamori
Shunji
S
Ono
Yoshitaka
Y
Naoe
Tomoki
T
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D002454:Cell Differentiation / Q000187:drug effects; D019070:Cell Lineage / Q000187:drug effects; D004804:Eosinophils / Q000473:pathology*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology*; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide